Related Experiment Videos
[Comparative investigation of the mesoptometer and the nyktometer (author's transl)]
Abstract:
Mesopic vision and sensitivity to glare were measured in 31 patients, using the Nyktometer and the Mesoptometer, which work on different principles. The results obtained with the two devices were remarkably similar.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mechanism and dynamics of fatty acid photodecarboxylase.
Science (New York, N.Y.)·2021
Milk processing quality of suckled/milked goats: effects of milk accumulation interval and milking regime.
The Journal of dairy research·2016
A Nordic survey of management practices and owners' attitudes towards keeping horses in groups.
Journal of animal science·2015
[Type 2 Macular Telangiectasia: Pathogenesis-The Interplay Between Neurodegeneration and Metabolic Changes].
Klinische Monatsblatter fur Augenheilkunde·2026
Macular Telangiectasia Type 2: Current and Emerging Diagnostic Imaging Modalities.
Klinische Monatsblatter fur Augenheilkunde·2026
Straylight-Based Evaluation of Glare in Two Presbyopia-Correcting Intraocular Lenses.
Klinische Monatsblatter fur Augenheilkunde·2026
An Eight-Year Review of Paediatric Ophthalmic Surgical Services at a Tertiary Eye Centre in Malawi.
Klinische Monatsblatter fur Augenheilkunde·2026
The Pathological Work-Life Model of the Chronic Glaucoma Patient: Risk Factors and Therapeutic Tips.
Klinische Monatsblatter fur Augenheilkunde·2026
An unusual case of iris and lens colobomas: A case report.
Therapeutic advances in ophthalmology·2026
Transient monocular vertical hemifield loss as a rare acute oxaliplatin-induced ophthalmological side effect: a case report and review of the literature.
Therapeutic advances in drug safety·2026
Unveiling Otolith Mystery: Contemporary Testing Approaches and Their Clinical Significance.
World journal of otorhinolaryngology - head and neck surgery·2026
Transcriptomic profiling of thyroid eye disease orbital fibroblasts identifies sorafenib as a novel therapeutic.
Frontiers in endocrinology·2026